Tickerover
Healthcare

MDT Stock Analysis

Medtronic plc · current price $91.20 (+1.37% today) · Reports in 2 days

Top-tier setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
★★★★★
Top Tier
📊

The six-pillar scorecard

Momentum
71
Trending up strong
price trend
Growth
25
Barely growing
sales & profit growth
Quality
95
High quality
profitability & balance sheet
Valuation
60
Fairly priced
is the price fair?
Sentiment
55
Positive mood
analyst & crowd mood
Risk
79
Low risk
volatility & drawdown

Each pillar is scored 0-100 inside the stock’s own peer group, so a chipmaker is measured against chipmakers. These are quality descriptors, not buy or sell signals.

📉

The picture

What drove the scoreThe seven components contributing most, each read out of 100.
RSI zoneRSI zone: 100100GrowthGrowth: 60601-month momentum1-month momentum: 6262Trend strengthTrend strength: 8585Relative strengthRelative strength: 6565Earnings qualityEarnings quality: 7878FundamentalsFundamentals: 7878
Margin profileWhat survives each step down the income statement.
GrossGross: 65.3%65.3%OperatingOperating: 22.0%22.0%NetNet: 13.2%13.2%Free cash flowFree cash flow: 14.9%14.9%
EPS surpriseReported EPS against estimate, last four quarters.
2026-04: +56.0% vs estimate+56%2026-042026-01: +1.9% vs estimate+2%2026-012025-10: +3.5% vs estimate+3%2025-102025-07: +2.5% vs estimate+3%2025-07
👁

Hype Check

Reading MDT’s price and volume history…

The audit — what has to hold for this thesis

Checking the areas that decide this thesis…

AI-generated from the company’s own filings and recent coverage, and it can be incomplete or wrong. A PASS is a reading of the cited evidence, not a verified fact and not a reason to buy. Follow each citation to the source.

🛡

Dilution Check

Reading MDT’s filings…

📣

Latest earnings

LAST EARNINGS Medtronic plc (MDT)

Latest earnings

EPS
$1.26 vs $1.23 est · +2.5% vs estimate BEAT
Revenue
$9.81B · +14.3% YoY
Stock reaction (1M)
+6.4%
Beat streak
4 of last 4 quarters
💰

Valuation

P/E
24.5×
Forward P/E
14.2×
PEG
1.78
Price / Sales
3.2×
Price / Book
2.4×
EV / EBITDA
13.6×
Analyst target
$98.84
Target range
$78.00 – $121.00
Implied upside
+8.4%
🩺

Financial health

Gross margin
65.3%
Operating margin
22.0%
Net margin
13.2%
FCF margin
14.9%
Return on equity
9.8%
Debt / equity
0.58
Revenue growth YoY
+9.9%
EPS growth YoY
+18.3%
📈

Technicals

$73.3152-week range$106.33
RSI (14)
57
50-day MA
$85.49
200-day MA
$89.81
ATR (14)
1.93
Beta
0.57
1-month return
+6.4%
🗓️

Earnings

QuarterEPSEst.SurpriseResult
2025-07-31$1.26$1.23+2.5%Beat
2025-10-31$1.36$1.31+3.5%Beat
2026-01-31$1.36$1.34+1.9%Beat
2026-04-30$1.55$1.54+0.6%Beat
Beat 4 of the last 4 quarters.
🏛️

Ownership & risk

Short % of float
0.01%
Dividend yield
3.20%
Beta
0.57
📰

Latest news on MDT

🔗

Similar stocks in Healthcare

Frequently asked

What is MDT's Quant Score?

Medtronic plc (MDT) currently has a TickerMover Quant Score of 75/100, rated ★★★★★ Top Tier. The Quant Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Medtronic plc (MDT) a buy?

TickerMover does not give buy or sell recommendations. MDT scores 75/100 (★★★★★ Top Tier) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is MDT's score updated?

MDT's Quant Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF and peer comparison — free while in beta.

Open the dashboard for MDT →